Table 1 Comparison of data between COVID-19 positive and COVID-19 negative groups

N

182

117

Male

107(58.8%)

67(57.3%)

0.794

Age (years)

2.3(1.3–3.8)

2.1(1.2–3.5)

0.239

    ≤1 years

25(13.7%)

17(14.5%)

0.847

    1–5 years

130(71.4%)

85(72.6%)

0.819

    ≥5years

27(14.8%)

15(12.8%)

0.625

Time from fever onset to seizure

    <24 hours

163(89.6%)

101(86.3%)

0.396

    ≥24hours

19(10.4%)

16(13.7%)

0.396

Seizure types

    Generalized seizures

173(95.1%)

110(94.0%)

0.697

    Partial seizures

9(4.9%)

7(6.0%)

0.697

Seizure duration ≥ 15min

34(18.7%)

6(5.1%)

0.001

Status epilepticus

28(15.4%)

6(5.1%)

0.006

History of convulsions

82(45.1%)

43(36.8%)

0.155

Family history of convulsions

42(23.1%)

29(24.8%)

0.736

Seizure ≥ 2 time

99(54.4%)

48(41.0%)

0.024

Peak body temperature, ℃

39.5(39.0–40.0)

39.5(39.0–40.0)

0.019

Abnormal EEG

20/68(29.4%)

12/88(13.6%)

0.016

Simultaneous phenomenon

    Pharyngodynia

10(5.5%)

6(5.1%)

0.891

    Cough

79(43.4%)

51(43.5%)

0.975

    Vomiting

52(28.6%)

20(17.1%)

0.023

    Diarrhoea

9(4.9%)

8(6.8%)

0.490

    Dizziness/Headache

8(4.4%)

2(1.7%)

0.352

Labiratory results

    WBC(*10⁹/L)

5.9(4.7–7.6)

8.7(6.3–12.8)

< 0.001

    HB(g/dl)

12.1(11.6–12.7)

12.1(11.4–12.8)

0.295

    PLT(*10⁹/L)

212(183–258)

239(205–309)

< 0.001

    CRP(mg/L)

5.2(1.8–11.2)

9.0(2.8–30.7)

< 0.001